Cerón-Carrasco JP - Search Results

1

Theoretical Prediction of Dual-Potency Anti-Tumor Agents: Combination of Oxoplatin with Other FDA-Approved Oncology Drugs.

Cerón-Carrasco JP. Cerón-Carrasco JP. Int J Mol Sci. 2020 Jul 3;21(13):4741. doi: 10.3390/ijms21134741. Int J Mol Sci. 2020. PMID: 32635199 Free PMC article.

2

Using Theory To Reinterpret the Kinetics of Monofunctional Platinum Anticancer Drugs: Stacking Matters.

Veclani D, Melchior A, Tolazzi M, Cerón-Carrasco JP. Veclani D, et al. J Am Chem Soc. 2018 Oct 31;140(43):14024-14027. doi: 10.1021/jacs.8b07875. Epub 2018 Sep 11. J Am Chem Soc. 2018. PMID: 30185041

3

Norditerpenoids with Selective Anti-Cholinesterase Activity from the Roots of Perovskia atriplicifolia Benth.

Ślusarczyk S, Senol Deniz FS, Abel R, Pecio Ł, Pérez-Sánchez H, Cerón-Carrasco JP, den-Haan H, Banerjee P, Preissner R, Krzyżak E, Oleszek W, E Orhan I, Matkowski A. Ślusarczyk S, et al. Int J Mol Sci. 2020 Jun 23;21(12):4475. doi: 10.3390/ijms21124475. Int J Mol Sci. 2020. PMID: 32586060 Free PMC article.

4

Removal of an Azo Dye from Wastewater through the Use of Two Technologies: Magnetic Cyclodextrin Polymers and Pulsed Light.

Rodríguez-López MI, Pellicer JA, Gómez-Morte T, Auñón D, Gómez-López VM, Yáñez-Gascón MJ, Gil-Izquierdo Á, Cerón-Carrasco JP, Crini G, Núñez-Delicado E, Gabaldón JA. Rodríguez-López MI, et al. Among authors: ceron carrasco jp. Int J Mol Sci. 2022 Jul 29;23(15):8406. doi: 10.3390/ijms23158406. Int J Mol Sci. 2022. PMID: 35955538 Free PMC article.

5

Labelling Herceptin with a novel oxaliplatin derivative: a computational approach towards the selective drug delivery.

Cerón-Carrasco JP, Cerezo J, Requena A, Zuñiga J, Contreras-García J, Chavan S, Manrubia-Cobo M, Pérez-Sánchez H. Cerón-Carrasco JP, et al. J Mol Model. 2014 Sep;20(9):2401. doi: 10.1007/s00894-014-2401-7. Epub 2014 Aug 23. J Mol Model. 2014. PMID: 25149438

6

Antibodies as Carrier Molecules: Encapsulating Anti-Inflammatory Drugs inside Herceptine.

Cerón-Carrasco JP, Pérez-Sánchez H, Zúñiga J, Requena A. Cerón-Carrasco JP, et al. J Phys Chem B. 2018 Feb 22;122(7):2064-2072. doi: 10.1021/acs.jpcb.7b10749. Epub 2018 Feb 8. J Phys Chem B. 2018. PMID: 29377693

7

Tuning the Optical Properties of Novel Antitumoral Drugs Based on Cyclometalated Iridium(III) Complexes.

Cerón-Carrasco JP, Zúñiga J, Requena A. Cerón-Carrasco JP, et al. J Phys Chem A. 2019 Oct 10;123(40):8644-8649. doi: 10.1021/acs.jpca.9b06216. Epub 2019 Oct 1. J Phys Chem A. 2019. PMID: 31536343

8

Using Theory To Extend the Scope of Azobenzene Drugs in Chemotherapy: Novel Combinations for a Specific Delivery.

Cerón-Carrasco JP, Jacquemin D. Cerón-Carrasco JP, et al. ChemMedChem. 2021 Jun 7;16(11):1764-1774. doi: 10.1002/cmdc.202100046. Epub 2021 Mar 18. ChemMedChem. 2021. PMID: 33619857

9

DFT Simulation of Structural and Optical Properties of 9-Aminoacridine Half-Sandwich Ru(II), Rh(III), and Ir(III) Antitumoral Complexes and Their Interaction with DNA.

Cerón-Carrasco JP, Ruiz J, Vicente C, de Haro C, Bautista D, Zúñiga J, Requena A. Cerón-Carrasco JP, et al. J Chem Theory Comput. 2017 Aug 8;13(8):3898-3910. doi: 10.1021/acs.jctc.7b00139. Epub 2017 Jul 6. J Chem Theory Comput. 2017. PMID: 28641006

10

Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo.

Yuan S, Chan JF, den-Haan H, Chik KK, Zhang AJ, Chan CC, Poon VK, Yip CC, Mak WW, Zhu Z, Zou Z, Tee KM, Cai JP, Chan KH, de la Peña J, Pérez-Sánchez H, Cerón-Carrasco JP, Yuen KY. Yuan S, et al. Antiviral Res. 2017 Sep;145:33-43. doi: 10.1016/j.antiviral.2017.07.007. Epub 2017 Jul 14. Antiviral Res. 2017. PMID: 28712942

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

63 results

Search Page